Back
ESC2025 Premium Access

Incidence of cardiovascular events following vericiguat initiation in patients with heart failure with or without a recent worsening heart failure event: a hospital-based real-world cohort study

Session: Comprehensive heart failure care
Topic: Pharmacotherapy
Speaker: Assistant Professor S. Kohsaka (Tokyo, JP)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Assistant Professor Shun Kohsaka

Keio University School of Medicine, Tokyo (Japan)
3 presentations
2 followers

7 more presentations in this session

The role of a structured patient education programme in the complex care of patients with heart failure

Speaker: Doctor F. Banfi-Bacsardi (Budapest, HU)

Access
Abstract
Slides
Video
Like
Thumbnail

Virtual multidisciplinary team (vMDT) platform: enhancing workforce productivity in community heart failure care

Speaker: Doctor M. Akram (Lincoln, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Prognostic value of combined assessment of heart rate rise and recovery during cardiopulmonary exercise test on clinical outcomes in patients with chronic heart failure

Speaker: Doctor Y. Shimono (Sapporo, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Unveiling gaps in heart failure management in Germany: a retrospective analysis of national data and healthcare utilisation patterns

Speaker: Professor J. Muller-Ehmsen (Bremen, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Exploring Kidney functions as a key barrier to effective diuresis in Congestion Refractory Heart Failure: Insights from the DEA-HF Clinical Trial

Speaker: Doctor I. Volis (Haifa, IL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Comprehensive heart failure care

Speakers: Assistant Professor S. Kohsaka, Doctor F. Banfi-Bacsardi, Doctor M. Akram, Doctor Y. Shimono, Professor J. Muller-Ehmsen...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources